Xinhai Wan

1.2k total citations
10 papers, 503 citations indexed

About

Xinhai Wan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xinhai Wan has authored 10 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Xinhai Wan's work include Prostate Cancer Treatment and Research (6 papers), Bone health and treatments (3 papers) and RNA modifications and cancer (1 paper). Xinhai Wan is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Bone health and treatments (3 papers) and RNA modifications and cancer (1 paper). Xinhai Wan collaborates with scholars based in United States, Argentina and Greece. Xinhai Wan's co-authors include Nora M. Navone, Jun Yang, Michael W. Starbuck, Elba S. Vázquez, Patricia Troncoso, Sankar N. Maity, Eleni Efstathiou, Vassiliki Tzelepi, Jin He and Huan Liu and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Xinhai Wan

10 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinhai Wan United States 9 235 208 185 119 63 10 503
Xiaohong Yan United States 13 233 1.0× 364 1.8× 157 0.8× 109 0.9× 33 0.5× 50 610
Veronica R. Placencio United States 8 354 1.5× 230 1.1× 212 1.1× 238 2.0× 48 0.8× 13 666
Sandra Gottschling Germany 11 154 0.7× 189 0.9× 107 0.6× 101 0.8× 74 1.2× 16 431
Jelena Urosevic Spain 8 221 0.9× 227 1.1× 72 0.4× 111 0.9× 21 0.3× 10 462
James Dean United Kingdom 8 212 0.9× 111 0.5× 134 0.7× 79 0.7× 32 0.5× 24 505
Miho Takami Japan 10 246 1.0× 412 2.0× 77 0.4× 66 0.6× 90 1.4× 18 600
Sarai Palanca Spain 13 221 0.9× 132 0.6× 103 0.6× 186 1.6× 28 0.4× 30 450
Takayuki Ninomiya Japan 8 165 0.7× 272 1.3× 153 0.8× 114 1.0× 27 0.4× 17 531
Claudia Blattmann Germany 14 237 1.0× 109 0.5× 235 1.3× 71 0.6× 21 0.3× 37 491
Abdo Abou-Slaybi United States 3 174 0.7× 181 0.9× 66 0.4× 84 0.7× 138 2.2× 6 423

Countries citing papers authored by Xinhai Wan

Since Specialization
Citations

This map shows the geographic impact of Xinhai Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhai Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhai Wan more than expected).

Fields of papers citing papers by Xinhai Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhai Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhai Wan. The network helps show where Xinhai Wan may publish in the future.

Co-authorship network of co-authors of Xinhai Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhai Wan. A scholar is included among the top collaborators of Xinhai Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhai Wan. Xinhai Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Meng, Chenling, Kevin Lin, Wei Shi, et al.. (2025). Histone methyltransferase ASH1L primes metastases and metabolic reprogramming of macrophages in the bone niche. Nature Communications. 16(1). 4681–4681. 3 indexed citations
2.
Labanca, Estefanía, Jun Yang, Peter D.A. Shepherd, et al.. (2021). Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer. European Urology Oncology. 5(2). 164–175. 20 indexed citations
3.
Sinha, Krishna M., Rozita Bagheri‐Yarmand, Yue Lu, et al.. (2019). Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene. 38(25). 5038–5049. 16 indexed citations
4.
Fong, Eliza Li Shan, Xinhai Wan, Jun Yang, et al.. (2015). A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Biomaterials. 77. 164–172. 85 indexed citations
5.
Liu, Zhiqiang, Jingda Xu, Jin He, et al.. (2015). Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 6(33). 34329–34341. 124 indexed citations
6.
Wan, Xinhai, Roberto P. Meiss, Jun Yang, et al.. (2013). Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells. PLoS ONE. 8(11). e80315–e80315. 17 indexed citations
7.
Wan, Xinhai, Jie Liu, Vassiliki Tzelepi, et al.. (2012). Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells. Clinical Cancer Research. 18(3). 726–736. 61 indexed citations
8.
Mohamedali, Khalid A., Zhigang Li, Michael W. Starbuck, et al.. (2011). Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature. Clinical Cancer Research. 17(8). 2328–2338. 18 indexed citations
9.
Tzelepi, Vassiliki, Jiexin Zhang, Guanglin Wu, et al.. (2011). Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features. Clinical Cancer Research. 18(3). 666–677. 105 indexed citations
10.
Wan, Xinhai, Zhigang Li, Jonathan M. Yingling, et al.. (2011). Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth. Bone. 50(3). 695–703. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026